Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MRK | good ridance mrk | 07/12/09 | 0 | 1.1K | |||
|
|||||||
MRK | maverick agm notes & tpi takeover analysis | 07/12/09 | 8 | 3.8K | |||
|
|||||||
MRK | invalid | 07/12/09 | 2 | 1.2K | |||
|
|||||||
MRK | Ann: Change of company name and code | 07/12/09 | 0 | 854 | |||
|
|||||||
MRK | name change | 04/12/09 | 2 | 1.4K | |||
|
|||||||
MRK | Ann: Appendix 3B / Top 20 Securityholders | 04/12/09 | 0 | 756 | |||
|
|||||||
MRK | Ann: Capital Reconstruction | 03/12/09 | 0 | 808 | |||
|
|||||||
MRK | Ann: Appendix 3B | 26/11/09 | 0 | 580 | |||
|
See All Discussions